Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
These guidelines were devloped in response to recent evidence that ARV drugs offer significant benefits in preventing HIV transmission.
The objectives of these guidelines are to provide:
- Updated, evidence-based clinical recommendations outlining a public health approach to providing ARV drugs for HIV treatment and prevention in the context of the continuum of HIV care, with a focus on settings with limited capacity and resources in the health system
- Guidance on key operational and service delivery issues that need to be addressed to increase access to HIV services, strengthen the continuum of HIV care and further integrate the provision of ARV drugs into health systems
- Programmatic guidance for decision-makers and planners at the national level on adapting, setting priorities for and implementing the clinical and operational recommendations and monitoring their implementation and impact
Last modified: April 13, 2020